Press Releases

Jun 1, 2026

Sofia Navarro

Press Releases

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Cosmos Health Inc. (NASDAQ:COSM) announced its entry into the global animal health sector by launching a veterinary formulation of its antimicrobial product C-Scrub Wash 4%. The product has passed stringent European veterinary disinfectant standards (EN 1656 and EN 1657) and is set to launch first in the UK, with plans for international expansion. …

COSM

Jun 1, 2026

Hana Yamamoto

Press Releases

Jiuzi Holdings Announces AI Intelligent Imaging Platform Achieves Milestone Progress and Advances Toward Commercial Deployment as Planned

Jiuzi Holdings announced significant progress in developing its AI intelligent imaging and data platform, moving forward with plans for commercial deployment. The platform integrates AI recognition, data processing, and cloud architecture to provide scalable, real-time analytics solutions designed for enterprise clients. Key features include facial…

JZXN

Jun 1, 2026

Priya Menon

Press Releases

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Greenwich LifeSciences reports promising open-label data from their Phase III FLAMINGO-01 clinical trial evaluating GLSI-100, an immunotherapy designed to prevent breast cancer recurrences. Preliminary results show a statistically significant increase in injection site immune reactions after multiple vaccinations in a non-HLA-A*02 patient arm, supp…

GLSI

Jun 1, 2026

Nina Shah

Press Releases

Osisko Development Announces Closings of Additional US$75 Million Aggregate Principal Amount of 4.125% Convertible Senior Notes Bringing Total Offering to US$300 Million

Osisko Development Corp. has completed a US$300 million offering of 4.125% convertible senior notes due 2031, including the full exercise of initial purchaser options and a private placement with Double Zero Capital. The proceeds, net of costs for capped call transactions to mitigate dilution, will fund the development and pre-construction activiti…

ODV

Jun 1, 2026

Nina Shah

Press Releases

Alpha Cash Cardholders To Get $2.50 Back Monthly on Certain Transit in 11 U.S. Cities

Alpha Modus Holdings announces that holders of its Alpha Cash Prepaid Mastercard will receive a $2.50 monthly rebate when spending $10 or more on public transit across 11 major U.S. metropolitan areas via Mastercard's Public Transit Benefit. This program targets unbanked and underbanked consumers, offering them rewards previously unavailable throug…

AMOD

Jun 1, 2026

Maya Rios

Press Releases

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LifeMD, a Nasdaq-listed telehealth company, announced the immediate appointment of Umesh Sripad as Chief Technology Officer. Mr. Sripad brings over 20 years of experience in digital transformation and technology leadership from major consumer and healthcare-related companies. His role will focus on leading LifeMD's technology strategy, platform tra…

LFMD

Jun 1, 2026

Maya Rios

Press Releases

MBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026

MBX Biosciences announced it will present new Phase 2 and one-year extension data on its once-weekly canvuparatide treatment for chronic hypoparathyroidism at the Endocrine Society's Annual Meeting (ENDO 2026). The company will also host an investor webcast to discuss the clinical trial results, highlighting progress toward Phase 3 development.

MBX

Jun 1, 2026

Marcus Reed

Press Releases

NuCana Appoints Ian Webster as Chief Financial Officer

NuCana plc, a clinical-stage biopharmaceutical company focused on cancer treatments, has appointed Ian Webster as Chief Financial Officer. Webster, formerly Interim CFO and Director of Finance, brings extensive financial and biopharmaceutical sector experience. His appointment comes as NuCana advances its Phase 2 clinical studies for NUC-7738 and N…

NCNA

Jun 1, 2026

Jordan Park

Press Releases

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Nasus Pharma announces a virtual key opinion leader event on June 10, 2026, to present NS002, its intranasal epinephrine powder for anaphylaxis treatment, featuring expert discussion of Phase 2 data showing faster and higher absorption compared to EpiPen. The event aims to showcase NS002's potential as a needle-free alternative addressing unmet med…

NSRX

Jun 1, 2026

Caleb Monroe

Press Releases

Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors

Aprea Therapeutics presented updated Phase 1 clinical trial data for their oral WEE1 inhibitor, APR-1051, at ASCO 2026. The data demonstrated preliminary anti-tumor activity, including partial responses and stable disease in heavily pretreated patients with advanced solid tumors, along with a favorable safety and tolerability profile. Enrollment is…

APRE

Jun 1, 2026

Caleb Monroe

Press Releases

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Spectral AI, Inc. announced the results of its 2026 Annual Meeting confirming all shareholder proposals, including board elections and audit firm ratification. The company highlighted its receipt of FDA De Novo classification for the DeepView System, enabling commercial distribution in the U.S. It also secured $31.7 million funding from BARDA, expa…

MDAI

Jun 1, 2026

Ajmal Hussain

Press Releases

BCB Appoints New CEO

BCB Bancorp, Inc., a New Jersey-based community bank holding company, has appointed Thomas M. O'Brien as President and Chief Executive Officer effective June 1, 2026. O'Brien brings extensive experience in community banking and aims to address recent operational and credit challenges faced by the company while focusing on regulatory compliance, cos…

BCBP

Jun 1, 2026

Hana Yamamoto

Press Releases

Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Lyell Immunopharma announced that its senior management will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference in June 2026, highlighting its progress in developing next-generation CAR T-cell therapies for cancer, and revealing its commercial manufacturing capacity to support product launches.

LYEL

Jun 1, 2026

Priya Menon

Press Releases

ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York

ALX Oncology Holdings Inc., a clinical-stage biotech company focusing on novel cancer treatments, announced its participation in a fireside chat at the 2026 Jefferies Global Healthcare Conference. The company highlighted its lead candidate evorpacept, advancing through multiple clinical trials, and its second candidate ALX2004 currently in a Phase …

ALXO

Jun 1, 2026

Nina Shah

Press Releases

MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology

MAIA Biotechnology presented a Trial in Progress poster at the 2026 ASCO Annual Meeting detailing its pivotal Phase 3 clinical trial THIO-104, evaluating the efficacy of its novel telomere-targeting agent ateganosine in combination with checkpoint inhibitors for third-line treatment in non-small cell lung cancer patients resistant to current therap…

MAIA

Jun 1, 2026

Marcus Reed

Press Releases

Outdoor Holding Company Appoints Director of AI Strategy & Implementation

Outdoor Holding Company (Nasdaq: POWW), the owner of GunBroker.com, appointed Erich Buerger as Director of AI Strategy & Implementation to lead the company’s AI initiatives. This strategic hire aims to enhance marketplace functionality, operational efficiency, and long-term shareholder value through disciplined AI deployment aligned with the compan…

POWW

Jun 1, 2026

Ajmal Hussain

Press Releases

Kaltura Named an Exemplary Provider in ISG Research Buyers Guide on Conversational AI

Kaltura has been named an Exemplary Provider in the ISG Research Buyers Guide on Conversational AI Emerging Providers. This accolade recognizes Kaltura's innovative conversational and agentic AI platform that enables personalized, real-time, context-aware digital engagement across multiple sectors. The company is expanding its AI capabilities throu…

KLTR

Jun 1, 2026

Caleb Monroe

Press Releases

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

Beyond Air, Inc. announced that the Nasdaq Hearings Panel has approved its request to continue listing on Nasdaq, provided the company regains compliance with the bid price requirement by July 31, 2026. The company plans to hold a shareholder vote on a reverse stock split to meet this requirement and remains focused on advancing its commercial and …

XAIR

Jun 1, 2026

Nina Shah

Press Releases

Agora, Inc. Announces Management Share Purchase Plan

Agora, Inc., a leader in conversational AI and real-time engagement technology, announced that its CEO Tony Zhao intends to invest up to $20 million in the company’s shares over the next 12 months. This management share purchase plan aims to demonstrate confidence in the company's growth prospects amid expanding market opportunities in real-time en…

API

Jun 1, 2026

Avery Klein

Press Releases

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

Immatics N.V. presented extended Phase 1b clinical trial data for its anzu-cel (IMA203) PRAME-targeted TCR T-cell therapy at the 2026 ASCO Annual Meeting, showing rapid, deep, and durable anti-tumor responses in heavily pretreated metastatic melanoma patients, including cutaneous and uveal subtypes. The therapy demonstrated a 56% confirmed overall …

IMTX

Jun 1, 2026

Ajmal Hussain

Press Releases

Viasat Selected by Lockheed Martin to Support NOAA Next-Generation Aircraft with Hybrid Satellite Communications Platform

Viasat Inc. has been selected by Lockheed Martin to supply high-bandwidth satellite communications technology for NOAA’s next-generation C-130J 'Hurricane Hunter' aircraft. This contract involves delivering Viasat's Hybrid SATCOM Approach technology to enable resilient, real-time data transmission supporting hurricane forecasting and severe weather…

VSAT

Jun 1, 2026

Derek Hwang

Press Releases

zSpace Eliminates Over $12 Million in Debt Through Conversion to Equity

zSpace, Inc., a provider of immersive augmented and virtual reality learning technology, announced it has converted more than $12 million of its outstanding debt into equity through agreements with lenders. This transaction eliminates related debt obligations, thus improving the company's financial foundation and enabling focus on its growth in edu…

ZSPC

Jun 1, 2026

Priya Menon

Press Releases

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

Senseonics Holdings announced plans for an analyst event and an oral presentation at the upcoming ADA 2026 Scientific Sessions to showcase recent commercial milestones and new real-world evidence for their implantable Eversense 365 Continuous Glucose Monitoring system. These events will focus on the system's performance, integration with insulin pu…

SENS

Jun 1, 2026

Leila Farooq

Press Releases

OpenPayd Targets Nasdaq Listing at Unicorn Valuation

OpenPayd has announced a definitive business combination with Titan Acquisition Corp. to become a publicly traded company on Nasdaq under the ticker OP. Valued at $1.145 billion on a pro-forma basis, OpenPayd operates a global financial infrastructure platform bridging traditional finance with digital assets, including stablecoins, via a single API…

OP

Jun 1, 2026

Ajmal Hussain

Press Releases

Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

Jasper Therapeutics, a clinical-stage biotech company focused on developing briquilimab for mast cell driven diseases, announced its Board of Directors will evaluate various strategic alternatives including asset sales, collaborations, merger, or wind-down, aiming to maximize shareholder value amid current market challenges. The company continues t…

JSPR